Evidence map›Paper›PMID 22111711›Full record

ReviewCritical reviews in eukaryotic gene expression2011

Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentials.

Catherine D Mao, Stephen W Byers

Abstract readReview
In one paragraph

Review in Critical reviews in eukaryotic gene expression, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Whole Exome Sequencing IdentifiesInternational journal of molecular sciences · 2021
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Role ofDiabetes · 2021
    Review
  14. Frontiers in cell and developmental biology · 2021
    Article
  15. Frontiers in oncology · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Catherine D MaoDepartment of Clinical Sciences, College of Health Sciences and Markey Cancer Center, University of Kentucky, Lexington, KY 40536, USA. cdmao2@uky.edu
Stephen W Byers
Georgetown University · USUniversity of Kentucky · US

Funding

Targeting CDK4 in TGS-B Inactivated Gastrointestinal CancersP01CA130821 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MISHRA, LOPA · 2008 to 2013
$6.9M
Beta-catenin-specific regulation of the vitamin D pathway in colon cancerR01CA129813 · NCI · GEORGETOWN UNIVERSITY · PI BYERS, STEPHEN W · 2008 to 2012
$1.6M
WNT13 &WNT13-signaling in Endothelial Cell SurvivalR01HL068698 · NHLBI · UNIVERSITY OF KENTUCKY · PI MAO, CATHERINE D · 2002 to 2005
$1.1M
Cross Regulation of Beta-catenin and Retinoid SignalingR01DK058196 · NIDDK · GEORGETOWN UNIVERSITY · PI BYERS, STEPHEN W · 2002 to 2004
$844k
Role of Matrix Metalloproteinase-1 in Endothelial Cell SenescenceR21AG031999 · NIA · UNIVERSITY OF KENTUCKY · PI MAO, CATHERINE D · 2009 to 2010
$335k
NCI NIH HHS P01 CA130821NCI NIH HHS P01-CA130821NCI NIH HHS R01 CA129813NCI NIH HHS R01-CA129813NHLBI NIH HHS R01 HL068698NHLBI NIH HHS R01-HL68698NIA NIH HHS R21 AG031999NIA NIH HHS R21-AG031999NIDDK NIH HHS R01 DK058196NIDDK NIH HHS R01-DK58196
6 · The paper itself

Abstract

Wnt signaling controls cell specification and fate during development and adult tissue homeostasis by converging on a small family of DNA binding factors, the T-cell factor/lymphoid enhancer factor (TCF/LEF) family. In response to Wnt signals, TCF/LEF members undergo a transcriptional switch from repression to activation mediated in part by nuclear β-catenin binding and recruitment of co-activator complexes. In mammals, the specificity and fine tuning of this transcriptional switch is also achieved by the cell-context-dependent expression of four members (TCF7, TCF7L1, TCF7L2, and LEF1) and numerous variants, which display differential DNA binding affinity and specificity, repression strength, activation potential, and regulators. TCF7/LEF1 variants are generated by alternative promoters, alternative exon cassettes, and alternative donor/acceptor splicing sites, allowing combinatorial insertion/exclusion of modular functional and regulatory domains. In this review we present mounting evidence for the interdependency of TCF7/LEF1 variant expression and functions with cell lineage and cell state. We also illustrate how the p53 and nuclear receptor family of transcription factors, known to control cell fate and to inhibit Wnt signaling, may participate in the fine tuning of TCF7/LEF1 repression/activation potentials.

Indexed as

Alternative SplicingAnimalsGene ExpressionHumansLymphoid Enhancer-Binding Factor 1MammalsNeoplasmsT Cell Transcription Factor 1TCF Transcription FactorsWnt Signaling PathwayLEF1 protein, humanLymphoid Enhancer-Binding Factor 1T Cell Transcription Factor 1TCF7 protein, humanTCF Transcription Factors

Identifiers

PMID22111711
PMCPMC3434703
OpenAlexW2028660446

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.